Ymmunobio at BIO-Europe 2026

Nov 9–11, 2026 Cologne, Germany ~5.8k attendees Website

Ymmunobio at BIO-Europe 2026 in Cologne: 1 session (1 talk).

OrganizationBIO-Europe 2026 Attendance
Biotech
Develops treatments for solid tumours aimed at NPTXR, a marker found on cancer cells but not healthy tissue.
Talk
Mon Nov 9
13:30–13:45
Oncology: Ymmunobio AG
An antibody-drug conjugate carrying two drugs, aimed at a protein found only on cancer cells in more than a dozen common cancers.

Explore the full BIO-Europe 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Cologne. Leave your work email and we’ll be in touch.

Privacy

Download the full BIO-Europe 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Ymmunobio

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by BIO-Europe or its organizers. Submit a correction